Inhibition of miR-34a reduces cellular senescence in human adipose tissue-derived mesenchymal stem cells through the activation of SIRT1

• Published in: Life sciences (1973) 2020-09, Vol.257, p.118055-118055, Article 118055
• Main Authors: Mokhberian, Neda, Bolandi, Zohreh, Eftekhary, Mohamad, Hashemi, Seyed Mahmoud, Jajarmi, Vahid, Sharifi, Kazem, Ghanbarian, Hossein
• Format: Article
• Language: English
• Subjects: Adipose tissue; Assaying; Biomedical materials; bone formation; CD44 antigen; Cell activation; Cell cycle; Cell proliferation; cell senescence; Cell therapy; Differentiation; Differentiation (biology); Evaluation; face; humans; medicine; Mesenchymal stem cells; miR-34a; p53 Protein; Polymerase chain reaction; Proliferation; quantitative polymerase chain reaction; Regenerative medicine; Senescence; SIRT1; SIRT1 protein; Stem cells; Telomerase reverse transcriptase; therapeutics; Tissue engineering; Western blotting; β-Galactosidase
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2020.118055

Human adipose derived mesenchymal stem cells (hAD-MSCs) as the most promising target for cell therapy and regenerative medicine, face senescence as a major drawback resulting in their limited proliferation and differentiation potentials. To evaluate the efficacy of miR-34a silencing as an anti-senescence strategy in hAD-MSCs, in this study common hallmarks of senescence were assessed after transient inhibition of miR-34a in hAD-MSCs. The expression levels of miR-34a in hAD-MSCs at different passages were evaluated by real-time quantitative PCR. hAD-MSCs at passage 2 and passage 7 were transfected with miR-34a inhibitor. Doubling time assay, colony forming assay, and cell cycle analysis were performed to evaluate cell proliferation rate. The activity of senescence associated β–galactosidase (SA-β-gal) was assessed by histochemical staining. Moreover, the senescence associated molecular alterations including that of pro-senescence (P53, P21 and P16) and anti-senescence (SIRT1, HTERT and CD44) genes were examined by quantitative RT-PCR and western blot assays. To evaluate the differentiation potentials of MSCs, following adipogenic and osteogenic induction, the expression levels of lineage specific markers were analyzed by qPCR. Our results showed that inhibition of miR-34a enhances the proliferation, promotes the adipogenic and osteogenic differentiation potency, reduces the senescence associated-β gal activity, and reverses the senescence associated molecular alterations in hAD-MSCs. In this study, we showed that inhibition of miR-34a reduces the cellular senescence through the activation of SIRT1. Our findings support the silencing of miR-34a as an anti-senescence approach to improve the therapeutic potentials of hAD-MSCs.